Artemis Investment Management LLP Eli Lilly & CO Transaction History

Artemis Investment Management LLP

$6.17 Billion
Q3 2024

A detailed history of Artemis Investment Management LLP transactions in Eli Lilly & CO stock. As of the latest transaction made, Artemis Investment Management LLP holds 55,474 shares of LLY stock, worth $44.1 Million. This represents 0.8% of its overall portfolio holdings.

Number of Shares

55,474

Previous 42,705 29.9%

Holding current value

$44.1 Million

Previous $38.7 Million 27.11%

% of portfolio

0.8%

Previous 0.55%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$772.14 - $960.02 $9.86 Million - $12.3 Million	12,769 Added 29.9%	55,474 $49.1 Million
Q2 2024 Jul 15, 2024	SELL	$724.87 - $909.04 $16.8 Million - $21.1 Million	-23,173 Reduced 35.18%	42,705 $38.7 Million
Q1 2024 Apr 16, 2024	SELL	$592.2 - $792.28 $441,189 - $590,248	-745 Reduced 1.12%	65,878 $51.3 Million
Q4 2023 Jan 17, 2024	SELL	$525.19 - $619.13 $20.7 Million - $24.4 Million	-39,479 Reduced 37.21%	66,623 $38.8 Million
Q3 2023 Oct 16, 2023	SELL	$434.7 - $599.3 $4.21 Million - $5.81 Million	-9,689 Reduced 8.37%	106,102 $57 Million
Q2 2023 Jul 19, 2023	BUY	$350.74 - $468.98 $40.6 Million - $54.3 Million	115,791 New	115,791 $54.3 Million
Q2 2022 Jul 22, 2022	SELL	$278.73 - $327.27 $26.5 Million - $31.1 Million	-95,026 Closed	0 $0
Q1 2022 Apr 21, 2022	BUY	$234.69 - $291.66 $22.3 Million - $27.7 Million	95,026 New	95,026 $27.2 Million
Q4 2020 Jan 26, 2021	SELL	$130.46 - $172.63 $4.99 Million - $6.6 Million	-38,214 Closed	0 $0
Q3 2020 Oct 29, 2020	SELL	$146.22 - $169.13 $435,004 - $503,161	-2,975 Reduced 7.22%	38,214 $5.65 Million
Q2 2020 Jul 27, 2020	BUY	$136.42 - $164.18 $1.95 Million - $2.34 Million	14,271 Added 53.02%	41,189 $6.78 Million
Q1 2020 Apr 14, 2020	BUY	$119.05 - $147.35 $3.2 Million - $3.97 Million	26,918 New	26,918 $3.73 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $22 Million - $25.9 Million	-197,851 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$105.9 - $118.64 $16.7 Million - $18.8 Million	-158,057 Reduced 44.41%	197,851 $22.9 Million
Q3 2018 Nov 09, 2018	BUY	$85.86 - $107.31 $8.42 Million - $10.5 Million	98,108 Added 38.06%	355,908 $38.2 Million
Q2 2018 Aug 08, 2018	BUY	$75.7 - $86.88 $19.5 Million - $22.4 Million	257,800 New	257,800 $22 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Artemis Investment Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Artemis Investment Management LLP with notifications on news.

Account

Artemis Investment Management LLP Eli Lilly & CO Transaction History